Philipp Blanke, MD, a Jonathan R. Weir-McCall, MBCHB, PHD, b Stephan Achenbach, MD,
c Victoria Delgado, MD, PHD, d Jörg Hausleiter, MD, e Hasan Jilaihawi, MD, f Mohamed …

This meta-analysis and systematic review was performed to evaluate the clinical relevance
of subclinical leaflet thrombosis (SLT) following transcatheter aortic valve replacement …

Abstract Aims The Valve Academic Research Consortium (VARC), founded in 2010, was
intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these …

Background Subclinical leaflet thrombosis of bioprosthetic aortic valves after transcatheter
valve replacement (TAVR) and surgical aortic valve replacement (SAVR) has been found …

Background Subclinical leaflet thrombosis, characterized by hypoattenuated leaflet
thickening (HALT) and reduced leaflet motion observed on 4-dimensional computed …

Background Subclinical leaflet thickening and reduced leaflet motion of bioprosthetic aortic
valves have been documented by four-dimensional computed tomography (CT). Whether …

Background: Although transcatheter aortic valve replacement (TAVR) therapy continues to
grow, there have been concerns about the occurrence of hypoattenuating leaflet thickening …

Cardiac computed tomography (CT) was initially developed as a non-invasive diagnostic
tool to detect and quantify coronary stenosis. Thanks to the rapid technological …

Background: Transcatheter heart valve (THV) thrombosis has been increasingly reported. In
these studies, thrombus quantification has been based on a 2-dimensional assessment of a …

Bioprosthetic valve (BPV) thrombosis is considered a relatively rare clinical entity. Yet a
more recent analysis involving a more systematic echocardiographic follow-up, the advent of …